Ether

Ether

SCHEMBL2211328

CCOCC.Nc1ccc(-c2ccc(O)cc2)cc1

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.54
ALDH1A1 P00352 2/20 0.54
HSD17B10 Q99714 2/20 0.54
CA3 P07451 1/20 0.54
THRB P10828 1/20 0.54
ALOX15 P16050 1/20 0.54
CA6 P23280 1/20 0.54
CASP1 P29466 1/20 0.54
HIF1A Q16665 1/20 0.54
CA14 Q9ULX7 1/20 0.54
APP P05067 3/20 0.48
ESR1 P03372 5/20 0.47
ESR2 Q92731 4/20 0.47
CYP19A1 P11511 2/20 0.47
TDP1 Q9NUW8 3/20 0.46
TP53 P04637 1/20 0.46
TSHR P16473 1/20 0.43
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.41
MAOA P21397 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
4-Aminophenol SCHEMBL7885759 0.94 CYP3A4 (0.62) CYP3A4ALDH1A1HSD17B10CA3THRB
Ether SCHEMBL371586 0.89 ESR1 (0.58) CYP3A4ALDH1A1HSD17B10CA3ALOX15
Benzidine SCHEMBL1056565 0.89 TDP1 (0.58) CYP3A4ALDH1A1HSD17B10ALOX15CA14
Benzidine SCHEMBL28724222 0.87 TDP1 (0.55) CYP3A4ALDH1A1HSD17B10ALOX15CA14
Benzidine SCHEMBL3146294 0.83 CYP3A4 (0.50) CYP3A4ALDH1A1HSD17B10ALOX15CA14
SCHEMBL523410 0.82 CYP3A4 (0.81) CYP3A4ALDH1A1HSD17B10CA3THRB
Benzidine SCHEMBL28242176 0.82 CYP3A4 (0.81) CYP3A4ALDH1A1HSD17B10CA3THRB
Ether SCHEMBL10630062 0.82 ESR1 (0.61) ESR1ESR2TAAR1
Hydroquinone SCHEMBL60032 0.82 LTA4H (0.52) CYP3A4ALDH1A1HSD17B10CA3ALOX15
Hydroquinone SCHEMBL8536783 0.82 LTA4H (0.52) CYP3A4ALDH1A1HSD17B10CA3ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257515-A1 RESIN COMPOSITION AND MOLDED ARTICLE MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2023-08-17 US disclosed
WO-2022004471-A1 RESIN COMPOSITION AND MOLDED ARTICLE 三菱瓦斯化学株式会社 2022-01-06 WO disclosed
EP-3202849-B1 FLOWABILITY IMPROVER FOR POLYCARBONATE AND POLYARYLATE, POLYCARBONATE RESIN COMPOSITION, POLYARYLATE RESIN COMPOSITION, AND MOLDED ARTICLE THEREOF KANEKA CORP (JP) 2020-05-13 EP disclosed
EP-3395894-B1 RESIN COMPOSITION AND ADHESIVE SHEET KANEKA CORP (JP) 2020-04-15 EP disclosed
US-10619004-B2 Flowability enhancing agent for polycarbonate resin, method for producing said agent, polycarbonate resin composition and molded article thereof KANEKA CORPORATION (JP) 2020-04-14 US disclosed
US-20200062893-A1 FLOWABILITY ENHANCING AGENT FOR POLYCARBONATE RESIN, METHOD FOR PRODUCING SAID AGENT, POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE THEREOF KANEKA CORPORATION (JP) 2020-02-27 US disclosed
US-20200040180-A1 POLYCARBONATE RESIN COMPOSITION AND MOLDED ARTICLE THEREOF KANEKA CORPORATION (JP) 2020-02-06 US disclosed
EP-3196224-B1 LIQUID CRYSTAL POLYMER UENO FINE CHEMICALS IND LTD (JP) 2019-11-13 EP disclosed
US-10377851-B2 Liquid crystal polymer UENO FINE CHEMICALS INDUSTRY, LTD. (JP) 2019-08-13 US disclosed
US-20190119490-A1 RESIN COMPOSITION, MOULDED ARTICLE, AND PLATED MOULDED ARTICLE KANEKA CORPORATION (JP) 2019-04-25 US disclosed
US-20130043425-A1 THERMOPLASTIC RESIN WITH HIGH THERMAL CONDUCTIVITY KANEKA CORPORATION (JP) 2013-02-21 US disclosed
EP-2479202-A1 THERMALLY-CONDUCTIVE ORGANIC ADDITIVE, RESIN COMPOSITION, AND CURED PRODUCT Kaneka Corporation (JP) 2012-07-25 EP disclosed
US-20120175549-A1 THERMALLY-CONDUCTIVE ORGANIC ADDITIVE, RESIN COMPOSITION, AND CURED PRODUCT KANEKA CORPORATION (JP) 2012-07-12 US disclosed
US-20110204282-A1 HIGHLY THERMALLY CONDUCTIVE THERMOPLASTIC RESIN COMPOSITION AND THERMOPLASTIC RESIN KANEKA CORPORATION (JP) 2011-08-25 US disclosed
EP-2348071-A1 HIGH THERMAL CONDUCTIVITY THERMOPLASTIC RESIN COMPOSITION AND THERMOPLASTIC RESIN Kaneka Corporation (JP) 2011-07-27 EP disclosed
EP-1103573-B1 LIQUID-CRYSTAL POLYMER UENO SEIYAKU OYO KENKYUJO KK (JP) 2004-09-15 EP disclosed
US-6755991-B2 ESPECIALLY 2,6-NAPHTHALENEDICARBOXYLIC ACID MIXED WITH 6-FORMYL-2-NAPHTHOIC ACID, 6-METHOXYCARBONYL-2-NAPHTHOIC ACID OR TRIMELLITIC ACID; ALKALI METAL COMPOUND KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO (JP) 2004-06-29 US disclosed
US-6388045-B1 CARBOXYLATED AROMATIC COMPOUND KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO (JP) 2002-05-14 US disclosed
US-20020045728-A1 Aromatic dicarboxylic acid composition and liquid crystalline polyester resin made from the same KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO 2002-04-18 US disclosed
EP-1103573-A1 LIQUID-CRYSTAL POLYMER KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO (JP) 2001-05-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120175549-A1 THERMALLY-CONDUCTIVE ORGANIC ADDITIVE, RESIN COMPOSITION, AND CURED PRODUCT MEP1A, SEM1, COL1A1 CYP3A4 3952/4885ALDH1A1 1666/4885HSD17B10 3879/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.